Anxiolytic-like effects of the selective 5-HT 1A receptor antagonist WAY 100635 in non-human primates

By Barros M.   Mello E.L.   Maior R.S.   Muller C.P.   de Souza Silva M.A.   Carey R.J.   Huston J.P.   Tomaz C.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite

Catalepsy induced by the 5-HT 1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

By Eltayb A.   Svensson T.H.   Ahlenius S.  

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite

Synergistic actions of the 5-HT 1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior

By Ahlenius S.   Larsson K.  

European Journal of Pharmacology, Vol. 379, Iss. 1, 1999-08 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT 1A receptor antagonist, on 8-OH-DPAT responses

By Trillat A.-C.   Malagie I.   Mathe-Allainmat M.   Anmela M.-C.   Jacquot C.   Langlois M.   Gardier A.M.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 41-49

Elsevier

Access to resources Recommend Favorite

Effects of 5-HT 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

By Assie M.-B.   Koek W.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 15-21

Elsevier

Access to resources Recommend Favorite